Tenofovir alafenamide plus dolutegravir as a switch strategy in HIV-infected patients: a pilot randomized controlled trial.

Autor: Alavian, Golbarg1 Golbarg.alavian@gmail.com, Abbasian, Ladan2 a-abbasian@tums.ac.ir, Khalili, Hossein3 khalilih@tums.ac.ir, Alinaghi, Seyed Ahmad Seyed4 s.a.alinaghi@gmail.com, Hasannezhad, Malihe5 mhasannezhad@sina.tums.ac.ir, Ashtiani, Masoumeh Farrokh6 Mfarrokhashtiani@gmail.com, Manshadi, Seyed Ali Dehghan6 a_dehghanm@sina.tums.ac.ir
Zdroj: DARU: Journal of Pharmaceutical Sciences. Dec2023, Vol. 31 Issue 2, p145-163. 9p.
Databáze: Academic Search Ultimate